Soleno Therapeutics
(NASDAQ) SLNO
This security has been delisted. This page is retained for historical reference.
SLNO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowSLNO Financials
Key Financial Metrics (TTM)
Gross Margin
98.63%
Operating Margin
30.80%
Net Income Margin
33.70%
Return on Equity
22.86%
Return on Capital
3.30%
Return on Assets
15.79%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$281.11M
Operating Income
$87.77M
EBITDA
$107.01M
Operating Cash Flow
$105.71M
Capital Expenditure
-$108.00K
Free Cash Flow
$105.60M
Cash & ST Invst.
$255.60M
Total Debt
$4.41M
Soleno Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$94.60M
N/A
Gross Profit
$93.41M
N/A
Gross Margin
98.73%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
115
N/A
Net Income
$31.38M
+171.7%
EBITDA
$36.72M
+187.6%
Quarterly Fundamentals
Total Cash
$255.60M
-11.8%
Total Debt
$4.41M
-91.7%
Accounts Receivable
$47.14M
N/A
Inventory
$17.31M
N/A
Long Term Debt
$3.24M
-93.8%
Short Term Debt
$1.16M
+94.8%
Return on Assets
15.79%
N/A
Return on Invested Capital
15.95%
N/A
Free Cash Flow
$25.94M
+179.2%
Operating Cash Flow
$25.98M
+179.3%